Related Experiment Video
Updated: Apr 27, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Leclercia adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome
Antonio Sanchez Porto1, Javier Casas Ciria1, Manuela Roman Enri1
1Hospital de La Linea de la Concepcion, Cadiz, Spain; Facultad de Medicina de Valladolid, Valladolid, Spain.
Abstract:
Leclercia adecarboxylata is being increasingly diagnosed as a causative agent of infection due to the availability of rapid molecular diagnostic techniques Few cases of bacteraemia in subjects with underlying medical conditions have been reported. We report a case of L. adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome.
Related Concept Videos
Fungal Phylum Microsporidia
Diabetic Ketoacidosis ll: Pathophysiology
Staphylococcal Skin Infections
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Nephrotic Syndrome I : Introduction
